AZD-4041

N/A

Report date: 2024/12/17 20:00:06
NME

Base Information

Drug NameAZD-4041
Drug Alias NameAZD-4041AZD4041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonists
TargetsOrexin receptor type 1
Therapy Area/IndicationsSmoking CessationOpioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEolas Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEolas Therapeutics IncAstrazeneca PlcMedimmune Llc
Inactive CompaniesN/A
Active IndicationsSmoking CessationOpioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A